{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T08:21:32Z","timestamp":1765959692602},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T00:00:00Z","timestamp":1358467200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Med Inform Decis Mak"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1472-6947-13-10","type":"journal-article","created":{"date-parts":[[2013,1,18]],"date-time":"2013-01-18T13:13:58Z","timestamp":1358514838000},"source":"Crossref","is-referenced-by-count":8,"title":["Designing concept maps for a precise and objective description of pharmaceutical innovations"],"prefix":"10.1186","volume":"13","author":[{"given":"Maia","family":"Iordatii","sequence":"first","affiliation":[]},{"given":"Alain","family":"Venot","sequence":"additional","affiliation":[]},{"given":"Catherine","family":"Duclos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2013,1,18]]},"reference":[{"key":"614_CR1","unstructured":"European Medicines Agency (EMA). Available at \n                    http:\/\/www.ema.europa.eu\/ema\/index.jsp?curl=\/pages\/home\/Home_Page.jsp&jsenabled=true\n                    \n                   (Accessed 01\/11\/2011)"},{"key":"614_CR2","unstructured":"The French agency for the safety of medicine and health products (ANSM). Available at \n                    http:\/\/ansm.sante.fr\/\n                    \n                   (Accessed 01\/11\/2012)"},{"key":"614_CR3","unstructured":"The French national authority for health (HAS). Available at \n                    http:\/\/www.has-sante.fr\/portail\/jcms\/j_5\/accueil\n                    \n                   (Accessed 30\/03\/2012)"},{"key":"614_CR4","unstructured":"U.S. Food and drug administration (FDA). Available at \n                    http:\/\/www.fda.gov\/default.htm\n                    \n                   (Accessed 01\/10\/2011)"},{"key":"614_CR5","doi-asserted-by":"publisher","first-page":"833","DOI":"10.7326\/0003-4819-154-12-201106210-00012","volume":"154","author":"GC Alexander","year":"2011","unstructured":"Alexander GC, O\u2019Connor AB, Stafford RS: Enhancing prescription drug innovation and adoption. Ann Intern Med. 2011, 154: 833-837.","journal-title":"Ann Intern Med"},{"key":"614_CR6","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1056\/NEJMp0906490","volume":"361","author":"RS Stafford","year":"2009","unstructured":"Stafford RS, Wagner TH, Lavori PW: New, but not improved? Incorporating comparative-effectiveness information into FDA labeling. N Engl J Med. 2009, 361: 1230-1233. 10.1056\/NEJMp0906490.","journal-title":"N Engl J Med"},{"key":"614_CR7","doi-asserted-by":"publisher","first-page":"516","DOI":"10.7326\/0003-4819-150-8-200904210-00106","volume":"150","author":"LM Schwartz","year":"2009","unstructured":"Schwartz LM, Woloshin S, Welch HG: Using a drug facts box to communicate drug benefits and harmstwo randomized trials. Ann Intern Med. 2009, 150: 516-527.","journal-title":"Ann Intern Med"},{"key":"614_CR8","first-page":"166","volume-title":"Proc AMIA Symp","author":"A Venot","year":"1999","unstructured":"Venot A, Duclos C: Methodology for the analysis and representation of the medical information about drugs in the summary of product characteristics (SPC). Proc AMIA Symp. 1999, 166-170."},{"key":"614_CR9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1055\/s-0038-1634502","volume":"37","author":"JH Liu","year":"1998","unstructured":"Liu JH, Milstein C, S\u00e9n\u00e9 B, Venot A: Object-oriented modeling and terminologies for drug contraindications. Methods Inf Med. 1998, 37: 45-52.","journal-title":"Methods Inf Med"},{"key":"614_CR10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-0038-1634501","volume":"37","author":"J Coste","year":"1998","unstructured":"Coste J, S\u00e9n\u00e9 B, Milstein C, Bou\u00e9e S, Venot A: Indicators for the automated analysis of drug prescribing quality. Methods Inf Med. 1998, 37: 38-44.","journal-title":"Methods Inf Med"},{"key":"614_CR11","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1055\/s-0038-1634615","volume":"34","author":"C Milstein","year":"1995","unstructured":"Milstein C, de Zegher I, Venot A, S\u00e9n\u00e9 B, Pietri P, Dahlberg B: Modeling drug information for a prescription-oriented knowledge base on drugs. Methods Inf Med. 1995, 34: 318-327.","journal-title":"Methods Inf Med"},{"key":"614_CR12","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1055\/s-0038-1634606","volume":"34","author":"B S\u00e9n\u00e9","year":"1995","unstructured":"S\u00e9n\u00e9 B, Venot A, de Zegher I, Milstein C, Errore S, de Rosis F, Strauch G: A general model of drug prescription. Methods Inf Med. 1995, 34: 310-317.","journal-title":"Methods Inf Med"},{"key":"614_CR13","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1055\/s-0038-1634248","volume":"39","author":"C Duclos","year":"2000","unstructured":"Duclos C, Venot A: Structured representation of drug indicationslexical and semantic analysis and object-oriented modeling. Methods Inf Med. 2000, 39: 83-87.","journal-title":"Methods Inf Med"},{"key":"614_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1197\/jamia.M1425","volume":"11","author":"C Duclos","year":"2004","unstructured":"Duclos C, Cartolano GL, Ghez M, Venot A: Structured representation of the pharmacodynamics section of the summary of product characteristics for antibioticsapplication for automated extraction and visualization of their antimicrobial activity spectra. J Am Med Inform Assoc. 2004, 11: 285-293. 10.1197\/jamia.M1425.","journal-title":"J Am Med Inform Assoc"},{"key":"614_CR15","unstructured":"Th\u00e9riaque. Available at \n                    http:\/\/www.theriaque.org\/\n                    \n                   (Accessed 30\/03\/2012)"},{"key":"614_CR16","unstructured":"Banque Claude Bernard BCB. Available at \n                    http:\/\/www.resip.fr\/\n                    \n                   (Accessed 30\/03\/2012"},{"key":"614_CR17","unstructured":"Vidal Expert. Available at \n                    http:\/\/www.vidal.fr\/les-produits-professionnels\/vidal-expert\n                    \n                   (Accessed 30\/03\/2012)"},{"key":"614_CR18","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1057\/palgrave.ivs.9500129","volume":"5","author":"JW Coffey","year":"2006","unstructured":"Coffey JW, Hoffman RR, Ca\u00f1as AJ: Concept map-based knowledge modelingperspectives from information and knowledge visualization. Inf Vis J. 2006, 5: 192-201. 10.1057\/palgrave.ivs.9500129.","journal-title":"Inf Vis J"},{"key":"614_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2105-7-267","volume":"7","author":"AG Castro","year":"2006","unstructured":"Castro AG, Rocca-Serra P, Stevens R, Taylor C, Nashar K, Ragan MA, Sansone SA: The use of concept maps during knowledge elicitation in ontology development processes \u2013 the nutrigenomics use case. BMC Bioinformatics. 2006, 7: 1-14. 10.1186\/1471-2105-7-1.","journal-title":"BMC Bioinformatics"},{"key":"614_CR20","unstructured":"FreeMind. Available at \n                    http:\/\/freemind.sourceforge.net\/wiki\/index.php\/Main_Page\n                    \n                   (Accessed 30\/11\/2011"},{"key":"614_CR21","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1016\/S0140-6736(00)02799-9","volume":"356","author":"R Edwards","year":"2000","unstructured":"Edwards R, Aronson JK: Adverse drug reactionsdefinitions, diagnosis, and management. Lancet. 2000, 356: 1255-1259. 10.1016\/S0140-6736(00)02799-9.","journal-title":"Lancet"},{"key":"614_CR22","unstructured":"U.S. FDA. \n                    http:\/\/www.fda.gov\/safety\/medwatch\/howtoreport\/ucm053087.htm\n                    \n                   (Accessed 30\/03\/2012)"},{"key":"614_CR23","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1331\/154434504773062582","volume":"44","author":"DC Malone","year":"2004","unstructured":"Malone DC, Abarca J, Hansten PD, Grizzle AJ, Armstrong EP, Van Bergen RC, Duncan-Edgar BS, Solomon SL, Lipton RB: Identification of serious drug-drug interactionsresults of the partnership to prevent drug-drug interactions. J Am Pharm Assoc. 2004, 44: 142-151. 10.1331\/154434504773062591.","journal-title":"J Am Pharm Assoc"},{"key":"614_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.2146\/ajhp070046","volume":"66","author":"JE Murphy","year":"2009","unstructured":"Murphy JE, Malone DC, Olson BM, Grizzle AJ, Armstrong EP, Skrepnek GH: Development of computerized alerts with management strategies for 25 serious drug-drug interactions. Am J Health Syst Pharm. 2009, 66: 38-44. 10.2146\/ajhp070046.","journal-title":"Am J Health Syst Pharm"},{"key":"614_CR25","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1111\/j.1365-2923.2010.03628.x","volume":"44","author":"J Daley","year":"2010","unstructured":"Daley J, Torre DM: Concept maps in medical educationan analytical literature review. Med Educ. 2010, 44: 440-448. 10.1111\/j.1365-2923.2010.03628.x.","journal-title":"Med Educ"}],"container-title":["BMC Medical Informatics and Decision Making"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1472-6947-13-10\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-13-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-13-10","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1472-6947-13-10.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T15:44:34Z","timestamp":1548171874000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmedinformdecismak.biomedcentral.com\/articles\/10.1186\/1472-6947-13-10"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,18]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1186\/1472-6947-13-10","relation":{},"ISSN":["1472-6947"],"issn-type":[{"value":"1472-6947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,18]]},"article-number":"10"}}